Collaborative Innovation at the Forefront of Singapore's Bioeconomy
The Agency for Science, Technology and Research and the National University of Singapore have established a new joint facility dedicated to advancing synthetic biology research toward practical commercial outcomes. Known formally as the A*STAR SIFBI-NUS Synthetic Biology Joint Lab and referred to as PRIME, the Platform for Research and Innovation in Metabolic Engineering, the initiative brings together complementary strengths from both institutions to bridge the gap between laboratory discoveries and industry-ready solutions.
Synthetic biology applies engineering principles to living organisms, enabling the design and construction of new biological parts, devices, and systems. In this context, researchers engineer microbes and enzymes to produce valuable compounds that traditionally rely on petrochemical processes or resource-intensive extraction from plants and animals. The PRIME lab targets applications in nutrition, consumer care, advanced materials, and health, supporting a broader shift toward sustainable manufacturing practices across Singapore's growing bioeconomy sector.
Strategic Context for Higher Education and Research Institutions
Singapore's higher education landscape emphasizes translational research that aligns with national economic priorities. The National University of Singapore, through its Synthetic Biology for Clinical and Technological Innovation centre, has built substantial expertise in fundamental synthetic biology approaches. Pairing this with A*STAR's Singapore Institute of Food and Biotechnology Innovation provides access to bioprocess development and scale-up capabilities essential for moving discoveries beyond the bench.
This partnership reflects ongoing efforts by Singapore universities and research agencies to strengthen industry linkages. Faculty members, postdoctoral researchers, and graduate students stand to benefit from expanded opportunities for collaborative projects that combine academic inquiry with real-world validation. The lab's emphasis on AI-guided design and automated workflows also introduces new interdisciplinary training pathways that integrate computational methods with biological engineering.
Launch Details and Key Leadership
The facility was officially launched on 11 June 2026. Leadership includes Professor Jay Keasling of the University of California, Berkeley, serving as lead principal investigator. Professor Keasling brings extensive experience in metabolic engineering, including pioneering work that enabled cost-effective production of complex molecules previously difficult to obtain at scale.
Representatives from both organisations attended the launch event, underscoring institutional commitment. A*STAR Chief Executive Officer Beh Kian Teik highlighted the importance of moving strong science closer to market. NUS Deputy President for Academic Affairs and Provost Aaron Thean emphasised the university's role in providing foundational science and talent development pathways. SIFBI Executive Director Sze Tan described the bioeconomy as the next industrial revolution, positioning the lab as a vehicle for sustainable innovation.
Core Research Priorities of the PRIME Lab
The joint lab organises its work around three interconnected pillars. The first focuses on accelerating design through AI-guided enzyme and pathway engineering, which shortens development timelines for new biological systems. The second addresses scalable production by establishing industrially relevant microbial platforms capable of manufacturing complex molecules at commercial volumes. The third explores access to novel bio-based compounds that offer functional advantages in ingredients and materials.
These priorities directly support companies seeking sustainable alternatives to conventional chemical manufacturing. Early emphasis falls on nutrition and consumer care products, with expansion planned into advanced materials and health applications. Engineered cell factories, often based on yeast or other microbes, convert simple feedstocks into high-value outputs without relying on traditional petrochemical routes.
Photo by Lusia Komala Widiastuti on Unsplash
Implications for Academic Training and Career Pathways
Beyond research outputs, the PRIME lab functions as a training hub for the next generation of scientists and engineers. Joint supervision arrangements, internships, and fellowships will expose students and early-career researchers to the interface between academia and industry. Skills in synthetic biology, metabolic engineering, AI-assisted biological design, and industrial biomanufacturing are increasingly sought after as companies expand their biotechnology capabilities.
For PhD candidates and postdoctoral scholars at NUS and affiliated institutions, participation offers exposure to translational workflows that complement traditional academic training. Administrators at Singapore universities may view such collaborations as models for aligning graduate programmes with emerging workforce needs in the bioeconomy. Faculty recruitment in related disciplines could also see heightened interest as the lab demonstrates concrete pathways from discovery to deployment.
Economic and Market Drivers Behind the Initiative
Global demand for bio-based chemicals and synthetic biology solutions continues to expand. Market projections indicate the synthetic biology sector could exceed US$62 billion by 2030, while the broader bioeconomy is expected to contribute significantly to annual global value. Singapore positions itself to capture a share of this growth through targeted investments in research infrastructure and industry partnerships.
The PRIME lab supports diversification of raw material sources for the chemicals sector and development of novel sustainable products. By reducing reliance on imported or environmentally intensive inputs, the initiative contributes to supply chain resilience while advancing national goals around green manufacturing. Economic development agencies have noted that industrial biotechnology provides credible pathways for companies to meet sustainability targets.
Stakeholder Perspectives on Collaboration and Impact
Officials from A*STAR, NUS, and the Singapore Economic Development Board have expressed strong support for the joint lab's potential to strengthen Singapore's position in emerging technologies. The collaboration exemplifies how public research agencies and universities can pool resources to address translation challenges that individual institutions might face alone.
Industry partners stand to gain from co-development opportunities that test and validate new molecules under realistic production conditions. Academic stakeholders benefit from access to scale-up expertise and real-world application contexts that inform future research directions. The emphasis on talent pipelines ensures that Singapore's higher education system continues to produce graduates equipped for roles in both research-intensive and commercial environments.
Future Outlook and Expansion Potential
Over time, the PRIME lab aims to catalyse technology licensing, start-up formation, and additional partnerships that build a robust innovation ecosystem. Success in initial focus areas could pave the way for broader applications across multiple sectors. Continued integration of AI and automation is expected to further compress development cycles and lower barriers to commercialisation.
For Singapore's higher education sector, sustained investment in such facilities signals ongoing commitment to research excellence and relevance. Universities may explore similar models with other agencies to expand opportunities in high-growth fields. The lab also contributes to positioning Singapore as a hub for bioeconomy talent and innovation in the Asia-Pacific region.
Photo by DIANA HAUAN on Unsplash
Opportunities for Researchers and Institutions
Academics interested in synthetic biology or related disciplines can monitor announcements regarding fellowships and collaborative projects associated with the PRIME lab. Administrators may consider how similar joint initiatives could enhance their institutions' research portfolios and graduate outcomes. The focus on interdisciplinary skills development aligns with broader trends in higher education toward preparing students for complex, cross-sector challenges.
As the bioeconomy matures, demand for expertise at the intersection of biology, engineering, data science, and commercialisation is likely to increase. Singapore's universities are well placed to respond through expanded programmes and partnerships that build on the foundation established by this latest collaboration.